ATA260378A - Verfahren zur herstellung von neuen ergot-alkaloiden - Google Patents

Verfahren zur herstellung von neuen ergot-alkaloiden

Info

Publication number
ATA260378A
ATA260378A AT0260378A AT260378A ATA260378A AT A260378 A ATA260378 A AT A260378A AT 0260378 A AT0260378 A AT 0260378A AT 260378 A AT260378 A AT 260378A AT A260378 A ATA260378 A AT A260378A
Authority
AT
Austria
Prior art keywords
producing new
ergot alkaloids
new ergot
alkaloids
producing
Prior art date
Application number
AT0260378A
Other languages
English (en)
Other versions
AT369783B (de
Inventor
Enzo Beacco
Maria Luisa Bianchi
Anacleto Minghetti
Celestino Spalla
Original Assignee
Farmaceutici Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia filed Critical Farmaceutici Italia
Publication of ATA260378A publication Critical patent/ATA260378A/de
Application granted granted Critical
Publication of AT369783B publication Critical patent/AT369783B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/183Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing an indolo[4,3-F,G]quinoleine nucleus, e.g. compound containing the lysergic acid nucleus as well as the dimeric ergot nucleus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02Ergot alkaloids of the cyclic peptide type

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT0260378A 1977-04-19 1978-04-13 Verfahren zur herstellung von neuen ergot-alkaloiden AT369783B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16096/77A GB1584464A (en) 1977-04-19 1977-04-19 Ergot alkaloids

Publications (2)

Publication Number Publication Date
ATA260378A true ATA260378A (de) 1982-06-15
AT369783B AT369783B (de) 1983-01-25

Family

ID=10071128

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0260378A AT369783B (de) 1977-04-19 1978-04-13 Verfahren zur herstellung von neuen ergot-alkaloiden

Country Status (16)

Country Link
US (1) US4230854A (de)
JP (1) JPS53132599A (de)
AT (1) AT369783B (de)
BE (1) BE865921A (de)
CA (1) CA1113410A (de)
CH (1) CH637658A5 (de)
CS (1) CS212760B2 (de)
DE (1) DE2816773A1 (de)
DK (1) DK145701C (de)
FR (1) FR2387989A1 (de)
GB (1) GB1584464A (de)
HU (1) HU175173B (de)
IE (1) IE46797B1 (de)
NL (1) NL7804174A (de)
SE (1) SE7804362L (de)
SU (1) SU735154A3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH646166A5 (it) * 1980-09-30 1984-11-15 Linnea Sa Procedimento di sintesi parziale della vincamina e di alcaloidi indolici correlati.
FR2499589B1 (fr) * 1981-02-06 1985-11-15 Richter Gedeon Vegyeszet Procede pour regler la quantite et les proportions des alcaloides qui se forment lors de la fermentation
US4390625A (en) 1981-02-06 1983-06-28 Richter Gedeon Vegyeszeti Gyar Rt Method for controlling the amount and distribution of alkaloids formed in a fermentation process
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
HU190141B (en) * 1983-08-10 1986-08-28 Richter Gedeon Vegyeszeti Gyar Rt,Hu New process for production of clavin-type rye-smut alcaloids
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US8710092B2 (en) * 2009-12-23 2014-04-29 Map Pharmaceuticals, Inc. Substituted indolo 4,3 FG quinolines useful for treating migraine
KR20140042868A (ko) 2011-06-23 2014-04-07 맵 파마슈티컬스, 인코포레이티드 신규한 플루오로에르골린 유사체
WO2013095707A1 (en) 2011-12-19 2013-06-27 Map Pharmaceuticals, Inc. Novel iso-ergoline derivatives
SG11201403433PA (en) 2011-12-21 2014-07-30 Map Pharmaceuticals Inc Novel neuromodulatory compounds
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
CN116056762A (zh) 2020-06-12 2023-05-02 贝克利心理科技有限公司 包含5-甲氧基-n,n-二甲基色胺的苯甲酸盐的组合物
GB202212116D0 (en) 2022-08-19 2022-10-05 Beckley Psytech Ltd Pharmaceutically acceptable salts and Compositions thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH508628A (de) * 1968-06-25 1971-06-15 Sandoz Ag Verfahren zur Herstellung neuer heterocyclischer Verbindungen
CH534683A (de) * 1970-05-26 1973-03-15 Sandoz Ag Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
FI56386C (fi) * 1973-07-09 1980-01-10 Sandoz Ag Foerfarande foer framstaellning av oktahydro-oxazolo(3,2-a)pyrrolo(2,1-c)pyrazin-derivat
HU172649B (hu) * 1975-04-24 1978-11-28 Gyogyszerkutato Intezet Sposob poluchenija novykh biologicheski aktivnykh lizergamidov
CH619468A5 (de) * 1976-01-12 1980-09-30 Sandoz Ag
US4124712A (en) * 1976-09-06 1978-11-07 Sandoz Ltd. Ergot peptide alkaloid derivatives

Also Published As

Publication number Publication date
AT369783B (de) 1983-01-25
DK165778A (da) 1978-10-20
HU175173B (hu) 1980-05-28
SU735154A3 (ru) 1980-05-15
CS212760B2 (en) 1982-03-26
CH637658A5 (it) 1983-08-15
CA1113410A (en) 1981-12-01
IE780759L (en) 1978-10-19
DE2816773A1 (de) 1978-10-26
US4230854A (en) 1980-10-28
GB1584464A (en) 1981-02-11
FR2387989B1 (de) 1980-07-04
DK145701B (da) 1983-01-31
NL7804174A (nl) 1978-10-23
BE865921A (fr) 1978-07-31
FR2387989A1 (fr) 1978-11-17
IE46797B1 (en) 1983-09-21
DK145701C (da) 1983-07-18
JPS53132599A (en) 1978-11-18
SE7804362L (sv) 1978-10-20

Similar Documents

Publication Publication Date Title
AT367425B (de) Verfahren zur herstellung von neuen cephemderivaten
AT367426B (de) Verfahren zur herstellung von neuen cephemderivaten
AT372093B (de) Verfahren zur herstellung von neuen corticoid-17- alkylcarbonaten
AT362065B (de) Verfahren zur herstellung von neuen pleuromutilinglycosidderivaten
AT363182B (de) Verfahren zur herstellung von neuen cephemderivaten
AT368753B (de) Verfahren zur herstellung von neuen azacycloalkanen
AT371455B (de) Verfahren zur herstellung von neuen prostanderivaten
AT369783B (de) Verfahren zur herstellung von neuen ergot-alkaloiden
AT368137B (de) Verfahren zur herstellung von neuen 4-amino-5alkylthiopyrimidinen
AT357673B (de) Verfahren zur herstellung von neuen 9-amino- desoxyclavulansaeurederivaten
AT366368B (de) Verfahren zur herstellung von neuen chinolylguanidinen
LU78919A1 (de) Verfahren zur herstellung von neuen aminoalkoxyphenyl-derivaten
AT365591B (de) Verfahren zur herstellung von neuen indolderivaten
AT377988B (de) Verfahren zur herstellung von neuen phosphorderivaten von alkaloiden
AT361622B (de) Verfahren zur herstellung von neuen anthra- cyclinglycosid-anitbiotika
ATA472577A (de) Verfahren zur herstellung von neuen 1-acyl-4- -hydroxy-imidazol-5-carboxamid-derivaten
AT362368B (de) Verfahren zur herstellung von neuen oxazolidin- 2-on-derivaten
AT372690B (de) Verfahren zur herstellung von neuen polyhydantoinen
AT360676B (de) Verfahren zur herstellung von neuen 17beta- -hydroxy-4-androsten-3-onen
AT371109B (de) Verfahren zur herstellung von neuen benzolsulfonamidderivaten
AT362873B (de) Verfahren zur herstellung von neuen lasalocid-derivaten
AT365203B (de) Verfahren zur herstellung von neuen 9-fluorprednisolon-derivaten
AT361138B (de) Verfahren zur herstellung von neuen ergolin- derivaten
AT371119B (de) Verfahren zur herstellung von neuen sulfoximid-derivaten
AT363473B (de) Verfahren zur herstellung von neuen 4-hydroxy-thiazolidin-2-thion-derivaten